StonvexLoading…
StonvexStonvexStonvexCore line items from OTIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.57B | $14.43B | $10.63B | $6.95B |
Operating Income | $539.00M | $2.13B | $1.54B | $958.00M |
Net Income | $340.00M | $1.38B | $1.01B | $636.00M |
EPS (Diluted) | $0.87 | $3.50 | $2.55 | $1.60 |
Total Assets | $10.54B | $10.65B | $10.77B | $10.49B |
Total Liabilities | $15.98B | $15.92B | $16.06B | $15.70B |
Cash & Equivalents | $834.00M | $1.10B | $840.00M | $688.00M |
Free Cash Flow OCF − CapEx | $380.00M | $1.44B | $672.00M | $335.00M |
Shares Outstanding | 389.60M | 394.90M | 395.80M | 397.30M |